文献速递呼吸危重症与机械通气呼吸道感染

血浆线粒体DNA水平与创伤和脓毒症患者ARDS相关

Plasma Mitochondrial DNA Levels Are Associated With ARDS in Trauma and Sepsis Patients.
PubMed 文献 · Chest · 2019-10-14

在创伤和脓毒症两个前瞻性队列中,于急诊就诊时和约48小时后测定血浆mtDNA浓度。创伤患者ARDS发生率为18%(41/224),脓毒症患者为38%(45/120)。48小时mtDNA水平与ARDS显著相关(创伤OR 1.58/log copies/μL,95%CI 1.14-2.19,P=.006;脓毒症OR 1.52/log copies/μL,95%CI 1.12-2.06,P=.007),而就诊时mtDNA无显著关联。

要点

  • 48小时血浆mtDNA水平与创伤和脓毒症患者ARDS发生独立相关。
  • 就诊时mtDNA水平与ARDS无显著关联,提示动态监测时机重要。
  • 脓毒症非肺源性感染亚组中48小时mtDNA与ARDS关联更强(交互P=.014)。

核心结论

  • 血浆mtDNA水平与创伤和脓毒症患者新发ARDS相关,提示循环mtDNA可能是肺损伤的可干预介质。

研究设计与样本

  • 研究在创伤和脓毒症两个独立前瞻性队列中于急诊就诊时和约48小时后测定血浆mtDNA浓度。
  • 创伤队列224例,脓毒症队列120例,ARDS按柏林定义分类。
  • 采用多变量logistic回归分析mtDNA与ARDS的关联,并校正各人群中已知的ARDS危险因素。

主要发现

  • 创伤患者中41/224(18%)发生ARDS,脓毒症患者中45/120(38%)发生ARDS。
  • 48小时mtDNA水平与ARDS显著相关:创伤OR 1.58/log copies/μL(95%CI 1.14-2.19,P=.006),脓毒症OR 1.52/log copies/μL(95%CI 1.12-2.06,P=.007)。
  • 就诊时血浆mtDNA水平在两个队列中均与ARDS无显著关联。
  • 脓毒症患者中,48小时mtDNA与ARDS的关联在非肺源性感染亚组(OR 2.20/log copies/μL,95%CI 1.36-3.55,P=.001,n=69)强于肺源性感染亚组(OR 1.04/log copies/μL,95%CI 0.68-1.59,P=.84,n=51),交互作用P=.014。

临床怎么用

  • 对于创伤或脓毒症危重患者,可考虑在48小时左右监测血浆mtDNA水平以辅助ARDS风险分层。
  • 就诊时mtDNA水平不宜单独用于预测ARDS风险。
  • 脓毒症非肺源性感染患者中48小时mtDNA与ARDS关联更强,可能更需关注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Critically ill patients who develop ARDS have substantial associated morbidity and mortality. Circulating mitochondrial DNA (mtDNA) released during critical illness causes endothelial dysfunction and lung injury in experimental models. This study hypothesized that elevated plasma mtDNA is associated with ARDS in critically ill patients with trauma and sepsis. METHODS: Plasma mtDNA concentrations were measured at ED presentation and approximately 48 h later in separate prospective cohorts of critically ill patients with trauma and sepsis. ARDS was classified according to the Berlin definition. The association of mtDNA with ARDS was tested by using multivariable logistic regression, adjusted for covariates previously shown to contribute to ARDS risk in each population. RESULTS: ARDS developed in 41 of 224 (18%) trauma patients and in 45 of 120 (38%) patients with sepsis. Forty-eight-hour mtDNA levels were significantly associated with ARDS (trauma: OR, 1.58/log copies/μL; 95% CI, 1.14-2.19 [P = .006]; sepsis: OR, 1.52/log copies/μL; 95% CI, 1.12-2.06 [P = .007]). Plasma mtDNA on presentation was not significantly associated with ARDS in either cohort. In patients with sepsis, 48-h mtDNA was more strongly associated with ARDS among those with a nonpulmonary infectious source (OR, 2.20/log copies/μL; 95% CI, 1.36-3.55 [P = .001], n = 69) than those with a pulmonary source (OR, 1.04/log copies/μL; 95% CI, 0.68-1.59 [P = .84], n = 51; P = .014 for interaction). CONCLUSIONS: Plasma mtDNA levels were associated with incident ARDS in two critical illness populations. Given supportive preclinical data, our findings suggest a potential link between circulating mtDNA and lung injury and merit further investigation as a potentially targetable mediator of ARDS.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Faust HE, Reilly JP, Anderson BJ, et al. Plasma Mitochondrial DNA Levels Are Associated With ARDS in Trauma and Sepsis Patients. Chest. 2019. PMID: 31622590. doi:10.1016/j.chest.2019.09.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。